Additionally, our KC data show that diacerein may diminish skin inflammation but also may have potential implications for atherogenesis in psoriasis: diacerein inhibits IL-1-induced regulation of several inflammatory genes in KCs reported to have pro-atherogenic properties, downstream in the vasculature. Here, TBCE is linked to psoriasis.